1Kroegelc C, Bergmaun N, Heider C, et al. Interferon-alpha as treatment option in severe persistent uncontrolled bronchial asthma all open label study [J]. Pneumologie, 2009, 63(6): 307-313.
2Cousins DJ, Mc Donald J, Lec TH. Therapeutic approaches for control of transcription factors in allergic disease [J]. J Allergy Clin Immunol, 2008, 121(4): 803-809.
3Walker W, Healey GD, Hopkin JM. RNA interference of STAT6 rapidly attenuates ongoing ntefleukin-13-mediated events in lung epithelial ceils [J]. J Immunol, 2009, 127(2): 256-266.
4Sugita A, Ogawa H, Azuma M, et al. Anfiallergic and anti-inflammatory effccts of a novel IkappaB Idnase bern inhibitor, IMD-0354, in a mouse model of allergic inflammation [J]. Int Arch Allergy Immunol, 2009, 1480): 186-198.
5PlanagumA A, Kazani S, Mariqowda G, et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma [J]. Am J Respir Crit Care Med, 2008, 178(6): 574-582.
6Levy BD, Lukacs NW, Berlin AA, et al. Lipoxin A4 stable analogs reduce allergic airway responses via mechanisms distinct from CysLT1 receptor antagonism [J]. FASEB J, 2007, 21(14): 3877-3884.
7Yamamura K, Adachi T, Masuda T, et al. Intracellular protein phosphorylation in eosinophils and the functional relevance in cytokine production [J]. Int Arch Allergy Immunol, 2009, 149(1): 45-50.
8Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisonc-dependent asthma with sputum cosinophilia[J]. N Engl J Med, 2009, 360(10): 985-993.
9Deveci F, Muz MH, Ilhan N, et al. Evaluation of the anti-inflammatory effect of infliximab in a mouse model of acute asthma [J]. Respirology, 2008, 13(4): 488-497.
10Wenzel SE, Barnes PJ, Bleecker ER, et al. A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-a Blockade in Severe Persistent Asthma [J]. Am J Respir Crit Care Med, 2009, 179(7): 549-558.
3Bisset L R, Schmid-Grendelmeier P. Chemokines and their receptors in the pathogenesis of allergic asthma: progress and perspective [J ]. Curr Opin Pulm Med, 2005,11 ( 1 ) : 35-42.
4Gibbons F K, Israel E, Deykin A, et al. The combined effects of zafirlukast, prednisone, and inhaled budesonide on IL-13 and IFN- gamma secretion [ J ]. J Clin Immunol, 2005,25 (5) : 437-444.
5Fujimura Y, Functional morphology of microfold cell in peyer' spatches-phagocytosis and transport of BCG by M cells into rabbit peyer' spatches [J]. Gastraentern Jpn, 1986,21 (4) : 325-335.
6Ibsen M W, Bakken V, Jonsson R, et al. Immune response in mice after gastric and subcutaneous immunization with BCG [J]. Scand J Immunol, 1997,46(3) :274-280.
7Lagranderiea M, Chavarot P, Balazuca A M, et al. Immunogenieity and protective capacity of mycobacterium bovis BCG after oral or intragastric administration in mic [J]. Vaccine,2000, 18(13): 1186-1195.
8Mamoru Kawahara, Kazuhiro Matsuo, Mitsuo Honda, et al. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simianimmunodeficiency virus Gag protein induces long-lasting,antigen-specific immune responses in guinea pigs [J]. Clinical Immunology, 2006,119( 1 ) : 67-78.
9Shirakawa T, Enomoto F, Shimazu S, et al. The inverse association between tuberculin responses and atopic disorder.Science, 1997,275:77-79.
10Joos L, Carlen Brutsche IE, Laule-Kilian K, et al. Systemic TH1 and TH2-gene signals in atopy and asthma. Swiss Med Wkly,2004,134:159-164.
